As of Feb 20, 2025, Apple Relative Value is $36.1. This suggests it may be overvalued by 57.4% compared to its current price of around $22.9.
As of Feb 20, 2025, Fresenius Medical Care AG & Co. KGaA's Discounted Cash Flow (DCF) valuation estimates its share price at $65.7. This suggests it may be overvalued by 186.3% to its current price of around $22.9, using a discount rate of 4.8% and terminal growth rate of 3.0%.
As of Feb 20, 2025, Apple Intrinsic Value is $51.4. This suggests it may be undervalued by 123.9% compared to its current price of around $22.9.